These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24516210)

  • 1. Cross-boundary cancer studies at the University of Tokyo: Asia as a partner for Japan.
    Nishiyama M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i32-37. PubMed ID: 24516210
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities.
    Rigaudy P
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i54-59. PubMed ID: 24516214
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-boundary Cancer Studies at the University of Tokyo: View from the world of science and reason.
    Akaza H
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i3-5. PubMed ID: 24516209
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-boundary cancer studies at the University of Tokyo: Astellas in Asia: challenge for cancer.
    Nogimori M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i60-64. PubMed ID: 24516216
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-boundary cancer studies at the University of Tokyo: Changes in Japan's global health policies: current stage in approaches to strengthen health systems.
    Takemi K
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i65-68. PubMed ID: 24516217
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-boundary cancer studies at the University of Tokyo: What we can do to overcome cancer.
    Kato M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i48-53. PubMed ID: 24516213
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-boundary cancer studies at the University of Tokyo: Shining a light in the darkness: what can we see?
    Sasakawa Y
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i74-77. PubMed ID: 24516219
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-boundary cancer studies at the University of Tokyo: International public good in the Asia-Pacific Era.
    Yachi S
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i78-83. PubMed ID: 24516220
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-boundary cancer studies at the University of Tokyo: Opening a path through research to the future of cancer treatment.
    Noda T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i43-47. PubMed ID: 24516212
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-boundary cancer studies at the University of Tokyo: Measures to control cancer in Japan.
    Kakizoe T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i38-42. PubMed ID: 24516211
    [No Abstract]   [Full Text] [Related]  

  • 11. Joint Symposium of Korean Cancer Association & UICC-ARO-Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia.
    Park EC; Kawahara N; Nozaki S; Thabrany H; Yoshimi S; Park S; Lee DH; Akaza H; Roh JK
    Jpn J Clin Oncol; 2017 Sep; 47(9):889-895. PubMed ID: 28903533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-boundary cancer studies at the University of Tokyo: Surviving cancer in Asia: introduction.
    Akaza H; Kawahara N
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i1-2. PubMed ID: 24516204
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-boundary cancer studies at the University of Tokyo: The globalization of healthcare.
    Shibuya K
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i69-73. PubMed ID: 24516218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical guidelines for epilepsy].
    Tsuji S
    Nihon Rinsho; 2014 May; 72(5):803-8. PubMed ID: 24912279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-of-life vehicle recycling and international cooperation between Japan, China and Korea: Present and future scenario analysis.
    Che J; Yu JS; Kevin RS
    J Environ Sci (China); 2011 Jun; 23 Suppl():S162-6. PubMed ID: 25084584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-boundary cancer studies at the University of Tokyo: Deciphering the frontlines of medicine.
    Namihira E
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i13-16. PubMed ID: 24516205
    [No Abstract]   [Full Text] [Related]  

  • 17. Rebuilding patient-physician trust in China.
    Tucker JD; Wong B; Nie JB; Kleinman A;
    Lancet; 2016 Aug; 388(10046):755. PubMed ID: 27560268
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-boundary cancer studies at the University of Tokyo: Using genome science to decipher cancer in Asia.
    Sugano S
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i17-21. PubMed ID: 24516206
    [No Abstract]   [Full Text] [Related]  

  • 19. The 7th Asia Cancer Forum: from the perspective of human security, how can we collaborate as Asians in order to place cancer on the global health agenda? How can we fill in the gaps that exist among us?
    Kawahara N; Roh JK; Akaza H; Inoue H; Shibuya K; Iwasaki M; Tsuji T; Nishiyama M; Nakagawara A; Watanabe K; Nozaki S; Inoue M; Sugimura H; Miyake J; Li F
    Jpn J Clin Oncol; 2011 Jun; 41(6):825-31. PubMed ID: 21531734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-boundary cancer studies at the University of Tokyo: Current status and outlook for Japan's healthcare system: focus on the response to the aging society.
    Tsuji T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i22-27. PubMed ID: 24516207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.